Literature DB >> 29449190

Adjuvant therapy for women with high-risk endometrial carcinoma.

Sean C Dowdy1, Gretchen E Glaser2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29449190     DOI： 10.1016/S1470-2045(18)30091-3

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  Muscle radiodensity loss during cancer therapy is predictive for poor survival in advanced endometrial cancer.

Authors:  Jie Lee; Jhen-Bin Lin; Meng-Hao Wu; Ya-Ting Jan; Chih-Long Chang; Chueh-Yi Huang; Fang-Ju Sun; Yu-Jen Chen
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-05-15       Impact factor: 12.910

2.  Construction of Endometrial Carcinoma ceRNA Network and Screening of Key Genes Based on TCGA Database.

Authors:  Yuchun Song; Ping Chu; Pan Li; Fengling Li
Journal:  Comput Math Methods Med       Date:  2022-07-04       Impact factor: 2.809
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.